Gastrointestinal cancer & Proton Therapy
February 7, 2023
Video file
Please connect to access this resource and get a more personalized Campus experience
No account yet? Request access
Executive summary
Jim Metz presents the rationale behind using proton therapy for gastrointestinal tumors. In this insightful presentation, he focuses on esophageal cancer, pancreas cancer, and anal cancer. Watch the talk's recording now!
Top cancer treatments
Guest speakers
James
Metz
Chair of Penn Medicine Roberts Proton Therapy Center
University of Pennsylvania
Related contents
Proton Therapy Publication
September 2024
Cost-utility analysis of proton beam therapy for locally advanced esophageal cancer in Japan.
Proton Therapy Publication
September 2024
Particle therapy in gastrointestinal cancer-a narrative review.
Proton Therapy Publication
September 2024
Clinical Outcomes of Proton Beam Therapy for Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Retrospective Study.
Proton Therapy Publication
June 2024
Effectiveness and Safety of Carbon Ion Radiotherapy in Solid Tumors: A Systematic Review and Meta-Analysis.
Proton Therapy Publication
June 2024
Optimizing GRID and Lattice Spatially Fractionated Radiation Therapy: Innovative Strategies for Radioresistant and Bulky Tumor Management.
Proton Therapy Publication
May 2024
PTCOG Gastrointestinal Subcommittee Lower Gastrointestinal Tract Malignancies Consensus Statement.
Proton Therapy Publication
May 2024
Comparing 90-Day Postoperative Mortality After Neoadjuvant Proton-Based Versus Photon-Based Chemoradiotherapy for Esophageal Cancer.
Proton Therapy Publication
May 2024
Proton Beam Radiotherapy as a Curative Alternative to Radiofrequency Ablation for Newly Diagnosed Hepatocellular Carcinoma.
Proton Therapy Publication
May 2024
Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma.